Novosibirsk TB Research Institute

From Wikipedia, the free encyclopedia
Novosibirsk Tuberculosis Research Institute
AbbreviationNTRI
FormationOctober 4, 1943
Legal statusFederal State Budgetary Institution of the Ministry of Health of the Russian Federation
PurposeTuberculosis research and treatment
Location
  •  Russian Federation, 630040,  Novosibirsk, Okhotskaya Street, 81 "A"
Region served
Siberia and Far East of Russia
Membership
305 specialists
Director
Prof Vladimir A.Krasnov, MD, PhD
AffiliationsMinistry of Health of the Russian Federation WHO
Websitehttp://nsk-niit.ru/en

Novosibirsk Tuberculosis Research Institute (NTRI) (Russian: Новосибирский научно-исследовательский институт туберкулёза (ННИИТ- [nnʲɪˈit])) - is a Federal State Budgetary Institution of the Ministry of Health of the Russian Federation and it specializes in the research and treatment of tuberculosis. NTRI provides the organization of TB care to the population in the regions of the Siberian and Far Eastern Federal Districts of Russia.

History[]

By the Order of Soviet of People's Commissars №19533-r from October 4, 1943 the Novosibirsk Tuberculosis Research Institute was established on the basis of equipment and personnel of the Central TB Research Institute,[1] which was evacuated from Moscow to Novosibirsk during The Great Patriotic War, World War II, in 1941.

Order of the Council of People's Commissars of the USSR#19533-r 4 October 1943 (in Russian)

Structure[]

The Institute has the following departments:

Leaders[]

The first director of the Novosibirsk Scientific Research Institute of Tuberculosis was Dr Alexandra Apollonovna Letunova. Later NTRI led by:

  • Anna Georgievna Aminina;
  • Rihard Karlovich Lozinger;
  • Mikhail Vasilievich Svirezhev;
  • Boris Nikolaevich Priss;
  • Igor Grigorievich Ursov;
  • Alexey Sevastyanovich Tarasov;
  • Vladimir Aleksandrovich Krasnov;
  • Acting Director since 10 December 2019 - Natalia Vasilievna Stavitskaya

Areas of expertise[]

NTRI provides clinical, scientific, organizational and methodological work.

Organizational and methodological: NTRI creates, supports and improves a system of effective TB control services for 21 subjects of the two federal districts of the Russian Federation:

NTRI provides MoH RF with epidemiological data and data analysis and forecasting.

Science: NTRI conducts preclinical, clinical trials of drugs and medical devices according to international standards, the Institution is providing with experimental design and analysis of specialized scientific publications and developed medical software products.

Clinic: NTRI as a tertiary level health care facility carries out all types of diagnostics and treatment of tuberculosis, including the provision of high-technological and specialized medical care for patients from the Siberian and Far Eastern Federal Districts of the Russian Federation. In the Institute, osteoplastic thoracoplasty (a variant of extrapleural thoracoplasty) has been used and improved for the last 50 years for patients with complicated cavitary forms of TB for whom lung resection is contraindicated.[2]

Since 2010 the NTRI is the Collaborating Centre of the World Health Organization (RUS-123).[3]

NTRI TB Bacteriological laboratory of NTRI is a Centre of Excellence (NCE-CRL) Supranational Reference Laboratories Network WHO (SRLN) [4]

References[]

  1. ^ in Russian: Central TB Research Institute of the Russian Academy of Medical Sciences
  2. ^ WHO. The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB. WHO: Geneva 2014. p.8
  3. ^ Collaborating Centre WHO-NTRI (RUS-123) on MDR TB Control training
  4. ^ NTRI Centre of Excellence (NCE-CRL)

External links[]

Retrieved from ""